Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2023 16:15 ET | Source: CVRx, Inc.

CVRx Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
January 12, 2023 17:30 ET | Source: CVRx, Inc.

CVRx to Report Fourth Quarter and Fiscal Year 2022 Financial and Operating Results and Host Conference Call on January 26, 2023

MINNEAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
January 09, 2023 08:45 ET | Source: CVRx, Inc.

CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
December 28, 2022 08:30 ET | Source: CVRx, Inc.

CVRx to Present at the 41st Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 28, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
December 20, 2022 16:05 ET | Source: CVRx, Inc.

CVRx Appoints Industry Veteran Kevin Hykes to Board of Directors

MINNEAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative...
November 16, 2022 08:00 ET | Source: CVRx, Inc.

CVRx to Present at the Piper Sandler 34th Annual Healthcare Conference

MINNEAPOLIS, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
November 03, 2022 10:31 ET | Source: CVRx, Inc.

CVRx Launches new Barostim NEO2™ Implantable Pulse Generator

The new Barostim NEO2 Implantable Pulse Generator (IPG) launches in the U.S., improving the patient experience while on therapy and simplifying the implant procedure for physicians MINNEAPOLIS, Nov. ...
November 03, 2022 08:30 ET | Source: CVRx, Inc.

CVRx to Attend Upcoming Investor Conferences

MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
November 01, 2022 16:15 ET | Source: CVRx, Inc.

CVRx Reports Third Quarter 2022 Financial and Operating Results

MINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...
October 18, 2022 16:30 ET | Source: CVRx, Inc.

CVRx to Report Third Quarter 2022 Financial and Operating Results and Host Conference Call on November 1st, 2022

MINNEAPOLIS, Oct. 18, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right